<DOC>
	<DOCNO>NCT00362726</DOCNO>
	<brief_summary>The purpose clinical research study assess effect Atazanavir 400 mg QD Atazanavir/Ritonavir 300/100 mg QD steady state single dose pharmacokinetics RGZ healthy subject .</brief_summary>
	<brief_title>Drug Interaction Study With Atazanavir Administered With Without Ritonavir Cytochrome P450 Substrate Rosiglitazone</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Healthy male female subject age 18 50 year old BMI 18 32 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>HIV</keyword>
</DOC>